Physician profile
Jonathan W Jantz
NPI 1952304677
$955.09
in general payments reported to CMS, 2019-2025
16 companies · $135 in 2025
The $135 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $64.29 · 2021: $120 · 2022: $58.22 · 2023: $208 · 2024: $232 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $353.27 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $129.94 | 2019-2024 | Jornay Pm |
| Sobi, INC | $70.32 | 2020-2023 | |
| Supernus Pharmaceuticals, INC. | $53.97 | 2021-2024 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $48.60 | 2019-2021 | |
| Tris Pharma INC | $44.95 | 2019-2024 | Dyanavel Xr |
| Corium, LLC | $44.20 | 2023 | Azstarys |
| Collegium Pharmaceutical, INC. | $39.25 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $34.88 | 2021-2023 | |
| Cranial Technologies, INC | $34.46 | 2025 | Doc Band |
| Adlon Therapeutics L.P. | $24.09 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $23.40 | 2023 | Flumist Quadrivalent |
| Shire North American Group INC | $14.99 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $13.94 | 2019 | |
| Exeltis, USA INC. | $13.77 | 2025 | Slynd |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Jantz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.